Tirzepatide (15mg) is a dual GIP and GLP-1 receptor agonist studied for its impact on type 2 diabetes and obesity. Research highlights its role in improving insulin sensitivity, regulating appetite, supporting weight loss, and offering potential cardiovascular benefits.
Tirzepatide (15mg) is a dual GIP and GLP-1 receptor agonist studied for its impact on type 2 diabetes and obesity. Research highlights its role in improving insulin sensitivity, regulating appetite, supporting weight loss, and offering potential cardiovascular benefits.
This website uses cookies to improve your experience. By clicking “Deny”, you consent to the use of Necessary cookies only. You may also accept selected cookies only.
